Cargando…
Senescent T cells: a potential biomarker and target for cancer therapy
The failure of T cells to eradicate tumour cells in the tumour microenvironment is mainly due to the dysfunction of T cells. Senescent T cells, with defects in proliferation and effector functions, accumulate in ageing, chronic viral infections, and autoimmune disorders where antigen stimulation per...
Autores principales: | Zhang, Jie, He, Tianhui, Xue, Lixiang, Guo, Hongyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170103/ https://www.ncbi.nlm.nih.gov/pubmed/34049248 http://dx.doi.org/10.1016/j.ebiom.2021.103409 |
Ejemplares similares
-
Ascitic Senescent T Cells Are Linked to Chemoresistance in Patients With Advanced High-Grade Serous Ovarian Cancer
por: Zhang, Jie, et al.
Publicado: (2022) -
Senescence in chronic wounds and potential targeted therapies
por: Wei, Xuerong, et al.
Publicado: (2022) -
The Potential of Senescence as a Target for Developing Anticancer Therapy
por: Jo, Hyein, et al.
Publicado: (2023) -
Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage
por: Wang, Hao, et al.
Publicado: (2018) -
Targeting cellular senescence to combat cancer and ageing
por: Wang, Chen, et al.
Publicado: (2022)